Invention Grant
- Patent Title: Crystalline form of a β-lactamase inhibitor
- Patent Title (中): β-内酰胺酶抑制剂的结晶形式
-
Application No.: US14212993Application Date: 2014-03-14
-
Publication No.: US09120795B2Publication Date: 2015-09-01
- Inventor: You Seok Hwang , Jian-Qiao Gu , Akash Jain , Sudhakar Garad , Jacob P. Sizemore
- Applicant: Cubist Pharmaceuticals, Inc.
- Applicant Address: US MA Lexington
- Assignee: Cubist Pharmaceuticals, Inc.
- Current Assignee: Cubist Pharmaceuticals, Inc.
- Current Assignee Address: US MA Lexington
- Agency: Lathrop & Gage LLP
- Agent Brian C. Trinque; David F. Cauble
- Main IPC: A61K31/439
- IPC: A61K31/439 ; C07D471/08
Abstract:
This disclosure provides compositions containing solid forms of sodium (2S,5R)-2-(1,3,4-oxadiazol-2-yl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate, and methods of manufacturing and using these compositions.
Public/Granted literature
- US20140275001A1 CRYSTALLINE FORM OF A BETA-LACTAMASE INHIBITOR Public/Granted day:2014-09-18
Information query
IPC分类:
